Funder
National Health and Medical Research Council
Centers for Disease Control and Prevention
Wellcome Trust
Reference24 articles.
1. Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure;Reynolds;Science,2022
2. Population immunity to pre-omicron and Omicron severe acute respiratory syndrome coronavirus 2 variants in US states and counties through 1 december 2021;Klaassen;Clin Infect Dis,2022
3. SARS-CoV-2 seroprevalence, cumulative infections, and immunity to symptomatic infection – a multistage national household survey and modelling study, Dominican Republic, June–October 2021;Nilles;Lancet Reg Health Am,2022
4. Immunological characteristics govern the transition of COVID-19 to endemicity;Lavine;Science,2021
5. Monitoring temporal changes in SARS-CoV-2 spike antibody levels and variant-specific risk for infection, Dominican republic, March 2021–august 2022;Nilles;Emerg Infect Dis J,2023